Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 725 of 2529 entries
View as:

Study of AMN107 With Imatinib in Gastrointestinal Stromal Tumors (GIST)

Phase: N/A Priority: Normal
NCT ID: NCT00135005 Org: User:
Start: 08/31/05 End: 11/30/06 Due: 11/30/07

A Study to Evaluate the Safety and Efficacy of Zoledronic Acid in the Prevention or Delaying of Bone Metastasis in Patients With Stage IIIA and IIIB Non-small Cell Lung Cancer (NSCLC)

Phase: N/A Priority: Normal
NCT ID: NCT00172042 Org: User:
Start: 03/31/05 End: 06/30/10 Due: 06/30/11

Phase IV Study of the Safety and Efficacy of Everolimus in Adult Patients With Progressive pNET in China

Phase: N/A Priority: Normal
NCT ID: NCT02842749 Org: User:
Start: 03/14/16 End: 02/22/24 Due: 02/22/25

A Phase Ib/II Study of the Combination of BYL719 Plus AMG 479 in Adult Patients With Selected Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT01708161 Org: User:
Start: 11/27/12 End: 06/01/17 Due: 06/01/18

Ease of Use and Microbial Contamination of Tobramycin Inhalation Powder (TIP) Versus Nebulised Tobramycin Inhalation Solution (TIS) and Nebulised Colistimethate (COLI)

Phase: N/A Priority: Normal
NCT ID: NCT01844778 Org: User:
Start: 08/31/13 End: 10/31/15 Due: 10/31/16

Phase Ib of Abiraterone Acetate Plus BEZ235 or BKM120 in Castration-resistant Prostate Cancer (CRPC) Patients

Phase: N/A Priority: Normal
NCT ID: NCT01634061 Org: User:
Start: 09/30/12 End: 07/31/15 Due: 07/31/16

Efficacy and Long-Term Safety of Vildagliptin as Add-on Therapy to Metformin in Patients With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT00860288 Org: User:
Start: 02/28/09 End: 03/31/11 Due: 03/31/12

Study Estimating the Clinical Difference Between 300 mg and 150 mg of Secukinumab Following Dose Escalation to 300 mg in Patients With Ankylosing Spondylitis

Phase: N/A Priority: Normal
NCT ID: NCT03350815 Org: User:
Start: 03/13/18 End: 05/29/21 Due: 05/29/22

Efficacy 2 Part Study of Identification of Keloid Biomarkers and Effect of QAX576 on Keloid Recurrence

Phase: N/A Priority: Normal
NCT ID: NCT00987545 Org: User:
Start: 06/30/09 End: 11/30/10 Due: 11/30/11

A Prostate Cancer Study in Men Undergoing Androgen Deprivation Therapy

Phase: N/A Priority: Normal
NCT ID: NCT00087659 Org: User:
Start: 12/31/03 End: 05/31/07 Due: 05/31/08

Treatment of Patients With RAD001 With Progressive Sarcoma

Phase: N/A Priority: Normal
NCT ID: NCT00767819 Org: User:
Start: 03/31/08 End: 05/17/17 Due: 05/17/18

Study of Efficacy, Safety, Tolerability, Pharmacokinetic (PK) and Pharmacodynamic (PD) of an Anti-CD40 Monoclonal Antibody, CFZ533, in Kidney Transplant Recipients

Phase: N/A Priority: Normal
NCT ID: NCT03663335 Org: User:
Start: 11/28/18 End: 10/29/21 Due: 10/29/22

A Safety and Efficacy Study of INC280 and Gefitinib in Patients With EGFR Mutated, c-MET-amplified NSCLC Who Have Progressed After EGFRi Treatment

Phase: N/A Priority: Normal
NCT ID: NCT01610336 Org: User:
Start: 04/05/12 End: 05/27/20 Due: 05/27/21

Survey Among Healthcare Professionals Treating Patients With Metastatic Breast Cancer in Selected European Countries to Evaluate Their Knowledge on Management of Hyperglycemia When Using Alpelisib

Phase: N/A Priority: Normal
NCT ID: NCT05073120 Org: User:
Start: 02/28/22 End: 06/05/24 Due: 06/05/25

Secukinumab Safety and Efficacy in Juvenile Psoriatic Arthritis (JPsA) and Enthesitis-related Arthritis (ERA)

Phase: N/A Priority: Normal
NCT ID: NCT03031782 Org: User:
Start: 05/23/17 End: 11/09/20 Due: 11/09/21

Managed Access Programs for TQJ230, Pelacarsen

Phase: N/A Priority: Normal
NCT ID: NCT07000695 Org: User:
Start: - End: - Due: -

A Study to Evaluate Real-world Brolucizumab Effectiveness and Safety in Japanese Patients With Neovascular Age-related Macular Degeneration (nAMD)

Phase: N/A Priority: Normal
NCT ID: NCT06699914 Org: User:
Start: 09/06/22 End: 12/01/23 Due: 12/01/24

A Study of Sabatolimab and Magrolimab-based Treatment in AML or Higher Risk MDS Participants

Phase: N/A Priority: Normal
NCT ID: NCT05367401 Org: User:
Start: 12/20/24 End: 10/26/29 Due: 10/26/30

Safety and Efficacy of FTY720 in Adult Patients Who Receive a Kidney Transplant

Phase: N/A Priority: Normal
NCT ID: NCT00099801 Org: User:
Start: 01/31/05 End: 03/31/06 Due: 03/31/07

Study of Power Doppler Ultrasound (PDUS) to Measure Response of Secukinumab Treatment in Patients With Active Psoriatic Arthritis (PsA)

Phase: N/A Priority: Normal
NCT ID: NCT02662985 Org: User:
Start: 08/22/16 End: 11/10/20 Due: 11/10/21

The Use of Zoledronic Acid to Prevent Cancer-treatment Bone Loss in Post-menopausal Women Receiving Adjuvant Letrozole for Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00171314 Org: User:
Start: 03/31/04 End: - Due: -

Study to Assess Safety, Tolerability, and Interactions of Cocaine and Oral AFQ056

Phase: N/A Priority: Normal
NCT ID: NCT04771143 Org: User:
Start: 07/21/21 End: 01/03/22 Due: 01/03/23

Impact of Formulary Coverage of Entresto (Sacubitril/Valsartan) on Prescription Abandonment/Rejection and Subsequent Treatment and Economic Outcomes in Chronic Heart Failure Patients in the U.S.

Phase: N/A Priority: Normal
NCT ID: NCT05848206 Org: User:
Start: 03/11/22 End: 04/29/22 Due: 04/29/23

Safety and Efficacy of LCL161 in Patients With Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT01098838 Org: User:
Start: 11/30/08 End: 01/31/11 Due: 01/31/12

Assessment of LCZ696 and Valsartan in Asian Patients With Salt-sensitive Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT01681576 Org: User:
Start: 08/31/12 End: 10/31/13 Due: 10/31/14